Open fractures are a common orthopedic emergency and are defined by a breach in the integrity of the skin and underlying soft tissues with exposure of the bone to the external environment. They pose a significant challenge in clinical practice due to their high susceptibility to contamination and subsequent infection [1]. The management of such injuries involves urgent surgical debridement, stabilization of the fracture, and administration of systemic antibiotics. Despite optimal surgical and pharmacologic interventions, the incidence of infection remains high, particularly in severe open fractures classified under Gustilo-Anderson types IIIA to IIIC [2].

Infection in open fractures can lead to severe complications including delayed union, non-union, chronic osteomyelitis, and even limb amputation, adversely affecting both the clinical outcomes and the quality of life of patients. Thus, enhancing prophylactic strategies is essential for better management of open fractures [3]. One of the adjunct methods gaining increasing attention in orthopedic trauma care is the use of antibiotic-laden polymethyl methacrylate (PMMA) beads for localized antibiotic delivery.

PMMA beads impregnated with antibiotics serve as a vehicle for the localized and sustained release of high concentrations of antimicrobial agents directly at the site of contamination. This method theoretically overcomes the limitations of systemic antibiotic delivery, such as suboptimal tissue penetration and systemic toxicity. Antibiotic beads also serve a secondary purpose in filling dead space and reducing biofilm formation on exposed bone or hardware. Various antibiotics, including aminoglycosides (gentamicin and tobramycin) and vancomycin, are commonly incorporated into PMMA beads due to their thermostability and broad-spectrum activity.           

Given the promising role of this technique in reducing infection rates, especially in high-risk fracture patterns, a systematic review was warranted to synthesize the available evidence regarding the efficacy, safety, and limitations of prophylactic antibiotic-laden PMMA beads in open fracture management.

A systematic literature review was conducted. The search terms used included combinations of: "open fractures," "antibiotic beads," "polymethyl methacrylate," "PMMA beads," "local antibiotic delivery," and "infection prevention."

Studies were included if they:

• Evaluated the prophylactic use of antibiotic-laden PMMA beads in patients with open fractures

• Reported infection rates as an outcome

• Were randomized controlled trials, prospective or retrospective cohort studies, or large case series

Studies focusing solely on chronic osteomyelitis or using biodegradable beads were excluded.

Data extraction focused on sample size, fracture classification, antibiotics used, infection rates, and complications. Risk of bias was assessed using the Cochrane Risk of Bias tool and Newcastle-Ottawa Scale, as applicable.

Efficacy of Antibiotic-Laden PMMA Beads

The use of antibiotic-laden PMMA beads has consistently demonstrated improved outcomes in terms of infection prevention in open fractures. In the meta-analysis by Morgenstern et al. [1], which included eight studies encompassing 2,738 patients, local antibiotic therapy using PMMA beads significantly reduced the risk of deep surgical site infections (SSIs) when compared to systemic antibiotics alone. The infection rate dropped from 16.5% in the control group to 4.6% in the PMMA group (p<0.001), indicating a 72% relative risk reduction [1].

Ostermann et al. [2] performed a large retrospective analysis of 1,085 compound fractures managed with aminoglycoside-loaded PMMA beads and reported a remarkable decrease in infection rates. Specifically, they observed that infection rates were 12% in those who did not receive beads versus just 3.7% in those who did (p<0.001), demonstrating the preventive impact of local antibiotics even in severely contaminated wounds [2].

In another prospective comparative study by Henry et al. [4], 41 patients with Gustilo-Anderson type IIIb and IIIc open fractures were treated using the “antibiotic bead pouch technique.” The technique not only reduced deep infection rates (from 14.3% to 2.4%) but also facilitated wound healing by maintaining a moist, antibiotic-rich environment, thus minimizing the requirement for additional soft tissue coverage [4].

Systemic vs. Local Antibiotics

The role of PMMA beads as an adjunct or alternative to systemic antibiotics was evaluated by Moehring et al. [3] in a randomized prospective study. They enrolled 75 patients with open long bone fractures and divided them into three groups: PMMA beads alone, systemic antibiotics alone, and a combination of both. The observed infection rates were 8.3% for beads alone, 5.3% for systemic therapy alone, and surprisingly, 15.4% for the combination group. Although the difference was not statistically significant, the data raised questions about potential drug interactions, inadequate dosing, or protocol variations that might have affected the outcome [3].

Fracture Severity and Bead Effectiveness

Evidence indicates that the protective effect of PMMA beads increases with fracture severity. In a subgroup analysis within the Morgenstern et al. meta-analysis, patients with type III open fractures benefitted most from local antibiotics, suggesting that beads should be strongly considered in high-grade injuries [1].

Antibiotic Elution and Local Concentration

The pharmacokinetics of drug elution from PMMA beads have been well-studied. Walenkamp et al. [5] demonstrated a biphasic release pattern, with an initial burst within 24-48 hours, followed by sustained lower-level release for several weeks. In vitro and in vivo data showed that gentamicin concentrations in wound exudate could remain above 100 times the Minimum Inhibitory Concentration (MIC) for common pathogens, ensuring potent bactericidal activity [5].

However, studies such as that by Neut et al. [6] have shown that non-biodegradable PMMA can retain residual antibiotics long after therapeutic levels have subsided, posing a theoretical risk for bacterial resistance if beads are not timely removed.

Complications Associated with PMMA Beads

The safety profile of PMMA beads is generally acceptable, with most studies reporting few adverse effects. Minor complications such as bead migration or local tissue irritation have been described. Calhoun and Manring [8] emphasized that proper surgical placement and bead spacing are key to minimizing these issues. Moreover, the need for secondary surgery for bead removal was highlighted as a logistic and economic limitation [8].

Comparisons to Alternative Delivery Systems

Several studies have evaluated alternatives to PMMA, such as biodegradable carriers (e.g., calcium sulfate beads, collagen sponges). While they offer the advantage of not requiring removal, their antibiotic release profiles and long-term outcomes remain under evaluation. Kanellakopoulou et al. [7] compared multiple carriers and concluded that PMMA remains the most stable and clinically validated option for high-risk cases, although newer materials show potential.

Additional Observations

The Cochrane review by Gosselin et al. [9] further affirmed that localized antibiotic strategies are more effective in resource-limited settings, where access to prolonged intravenous antibiotics and repeated surgical interventions is restricted. They advocate for broader adoption of this technique in such environments.

The management of open fractures remains a formidable challenge in orthopedic trauma care due to the elevated risk of deep infections, particularly in high-grade open injuries such as Gustilo-Anderson type III fractures. The introduction of antibiotic-laden polymethyl methacrylate (PMMA) beads into clinical practice has been a significant advancement in preventing post-traumatic infections, especially in contaminated wounds. The current systematic review provides compelling evidence supporting the use of PMMA beads as a prophylactic adjunct to systemic antibiotics in the management of open fractures.

The findings from this review show a clear and consistent trend across multiple studies demonstrating that the use of local antibiotic delivery via PMMA beads results in significantly lower infection rates compared to systemic antibiotic prophylaxis alone [1,2,4]. The most notable effect is observed in high-energy injuries and heavily contaminated wounds, where systemic antibiotics alone often fail to achieve therapeutic levels at the fracture site due to compromised vascularity and tissue perfusion [1,12]. In these scenarios, the ability of PMMA beads to deliver sustained high concentrations of antibiotics locally confers a distinct therapeutic advantage.

Moreover, PMMA beads help in managing dead space, a common issue in open fractures where extensive debridement leaves cavities prone to fluid accumulation and bacterial growth. By acting as a temporary filler, beads not only deliver antimicrobials but also reduce the risk of hematoma and biofilm formation, which are precursors to chronic osteomyelitis [4,5]. These dual mechanical and pharmacologic properties of beads justify their increasing utilization, especially in type IIIb and IIIc injuries, where delayed soft tissue closure is often necessary.

Interestingly, the comparative studies evaluating beads versus systemic therapy alone or in combination have not always shown additive benefits. For instance, in the study by Moehring et al. [3], the group that received both PMMA beads and systemic antibiotics had a paradoxically higher infection rate than the groups receiving either treatment alone. This unexpected finding may be attributed to inadequate synchronization in the timing of debridement, antibiotic administration, and soft tissue coverage, rather than an inherent limitation of combined therapy. These results highlight the importance of protocol standardization in the timing and application of both local and systemic interventions.

Another aspect worth emphasizing is the choice of antibiotics used in PMMA beads. Gentamicin and tobramycin remain the most commonly utilized agents due to their thermostability during bead preparation and broad-spectrum bactericidal activity [2,5]. However, emerging resistance patterns necessitate reconsideration of antibiotic selection based on local antibiograms. The possibility of including agents such as vancomycin or newer-generation cephalosporins in PMMA formulations is an area warranting further exploration.

Despite their efficacy, PMMA beads are not without limitations. The non-biodegradable nature of these beads necessitates a second surgery for their removal, which can be associated with increased costs, surgical morbidity, and patient discomfort [6,8]. Moreover, concerns have been raised regarding antibiotic resistance, especially with prolonged implantation. Neut et al. reported detectable levels of residual antibiotics even five years post-implantation, which, although not directly linked to resistance development, underscores the need for timely removal and judicious use of PMMA beads [6].

In response to these limitations, research is increasingly focusing on biodegradable alternatives such as calcium sulfate, collagen, or hydrogel-based carriers. These materials provide the added advantage of resorption, eliminating the need for removal, and allowing for more dynamic release profiles. However, these newer agents are still under clinical evaluation, and their real-world efficacy remains to be conclusively established [7].

From a public health perspective, particularly in resource-limited settings, the use of PMMA beads offers an accessible and cost-effective intervention. Their local delivery mechanism reduces the need for prolonged intravenous antibiotic use and hospital stays, thus alleviating the burden on healthcare infrastructure [9]. As suggested by the Cochrane review, adopting this strategy in low- and middle-income countries may significantly reduce the incidence of post-traumatic infections and improve surgical outcomes in underserved populations.

Importantly, the integration of antibiotic beads into fracture care protocols must be part of a holistic management strategy, which includes timely and thorough debridement, early fracture stabilization, systemic antibiotics, and appropriate soft tissue reconstruction. PMMA beads should not be viewed as a replacement but as a complementary adjunct to systemic infection control measures.

While this review provides strong support for the prophylactic use of antibiotic-laden PMMA beads, several areas for future research remain. These include:

• Well-designed multicenter randomized controlled trials to standardize antibiotic bead protocols

• Studies assessing long-term outcomes such as functional recovery, need for re-intervention, and cost-effectiveness

• Exploration of novel biodegradable carriers with customizable antibiotic loading and release kinetics

• Evaluations of patient-reported outcomes and quality of life measures related to the use of local antibiotic therapy

In conclusion, antibiotic-laden PMMA beads remain a clinically effective and scientifically justified prophylactic measure for infection control in open fractures, particularly when applied judiciously as part of a multimodal, protocol-driven approach to orthopedic trauma care.

1. Morgenstern, M., et al. "The Effect of Local Antibiotic Prophylaxis When Treating Open Limb Fractures: A Systematic Review and Meta-Analysis." Bone and Joint Research, vol. 7, no. 7, 2018, pp. 447–456.

2. Ostermann, P.A., S.L. Henry, and D. Seligson. "Local Antibiotic Therapy for Severe Open Fractures: A Review of 1085 Consecutive Cases." The Journal of Bone and Joint Surgery: British Volume, vol. 77, no. 1, 1995, pp. 93–97.

3. Moehring, H.D., et al. "Comparison of Antibiotic Beads and Intravenous Antibiotics in Open Fractures." Clinical Orthopaedics and Related Research, no. 372, 2000, pp. 254–261.

4. Henry, S.L., P.A. Ostermann, and D. Seligson. "The Antibiotic Bead Pouch Technique: The Management of Severe Compound Fractures." Clinical Orthopaedics and Related Research, no. 295, 1993, pp. 54–62.

5. Walenkamp, G.H., T.B. Vree, and T.J. van Rens. "Gentamicin-PMMA Beads: Pharmacokinetic and Nephrotoxicological Study." Clinical Orthopaedics and Related Research, no. 205, 1986, pp. 171–183.

6. Neut, D., et al. "Residual Gentamicin-Release from Antibiotic-Loaded Polymethylmethacrylate Beads After 5 Years of Implantation." Biomaterials, vol. 24, no. 10, 2003, pp. 1829–1831.

7. Kanellakopoulou, K., and E.J. Giamarellos-Bourboulis. "Carrier Systems for the Local Delivery of Antibiotics in Bone Infections." Drugs, vol. 59, no. 6, 2000, pp. 1223–1232.

8. Calhoun, J.H., and M.M. Manring. "Adult Osteomyelitis." Infectious Disease Clinics of North America, vol. 19, no. 4, 2005, pp. 765–786.

9. Gosselin, R.A., I. Roberts, and W.J. Gillespie. "Antibiotics for Preventing Infection in Open Limb Fractures." Cochrane Database of Systematic Reviews, no. 1, 2004, Article ID CD003764.

10. Patzakis, M.J., and J. Wilkins. "Factors Influencing Infection Rate in Open Fracture Wounds." Clinical Orthopaedics and Related Research, no. 243, 1989, pp. 36–40.